Nuvo Pharmaceuticals Inc (MRV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 68,907 | 73,775 | 69,546 | 19,998 | 17,523 |
| Cost of Goods | 24,396 | 23,309 | 26,472 | 8,638 | 8,115 |
| Gross Profit | 44,511 | 50,466 | 43,074 | 11,360 | 9,408 |
| Operating Expenses | 31,296 | 30,135 | 35,992 | 18,227 | 7,691 |
| Operating Income | 13,215 | 20,331 | 7,082 | -6,867 | 1,717 |
| Interest Expense | 10,253 | 11,925 | 12,756 | -32 | N/A |
| Other Income | -32,309 | -11,383 | 9,063 | 495 | -135 |
| Pre-tax Income | -29,347 | -2,977 | 3,389 | -6,340 | 1,582 |
| Income Tax | 2,858 | 1,152 | 28 | -187 | 1 |
| Net Income Continuous | -32,205 | -4,129 | 3,361 | -6,153 | 1,581 |
| Net Income | $-32,205 | $-4,129 | $3,361 | $-6,153 | $1,581 |
| EPS Basic Total Ops | -2.83 | -0.36 | 0.30 | -0.54 | 0.14 |
| EPS Basic Continuous Ops | -2.83 | -0.36 | 0.30 | -0.54 | 0.14 |
| EPS Diluted Total Ops | -2.83 | -0.36 | -0.51 | -0.54 | 0.12 |
| EPS Diluted Continuous Ops | -2.83 | -0.36 | -0.51 | -0.54 | 0.12 |
| EBITDA(a) | $-11,044 | $18,204 | $25,691 | $-3,879 | $1,975 |